{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T16:16:05Z","timestamp":1791821765773,"version":"4.3.4"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2014,2,18]],"date-time":"2014-02-18T00:00:00Z","timestamp":1392681600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0089467","type":"journal-article","created":{"date-parts":[[2014,2,18]],"date-time":"2014-02-18T22:41:17Z","timestamp":1392763277000},"page":"e89467","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":12,"title":["Fibrous Papule of the Face, Similar to Tuberous Sclerosis Complex-Associated Angiofibroma, Shows Activation of the Mammalian Target of Rapamycin Pathway: Evidence for a Novel Therapeutic Strategy?"],"prefix":"10.1371","volume":"9","author":[{"given":"Jung-Yi Lisa","family":"Chan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo-Hsien","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Lang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,2,18]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/jid.1965.118","article-title":"Fibrous papule of the nose: a clinicopathological study","volume":"45","author":"JH Graham","year":"1965","journal-title":"J Invest Dermatol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.0303-6987.2005.00362.x","article-title":"Histologic variants of fibrous papule","volume":"32","author":"C Bansal","year":"2005","journal-title":"J Cutan Pathol"},{"key":"ref3","first-page":"329","article-title":"Fibrous papule of the face","volume":"4","author":"WN Meigel","year":"1979","journal-title":"Am J Dermatopathol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1600-0560.1991.tb01237.x","article-title":"Fibrous papule of the nose with granular cells: two cases","volume":"18","author":"J Guitart","year":"1991","journal-title":"J Cutan Pathol"},{"key":"ref5","first-page":"353","article-title":"Fibrous papule of the face. A study of five cases by electron microscopy","volume":"1","author":"A Ragaz","year":"1979","journal-title":"Am J Dermatopathol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0190-9622(83)70142-8","article-title":"Fibrous papule: an immunohistochemical study with an antibody to S-100 protein","volume":"9","author":"J Spiegel","year":"1983","journal-title":"J Am Acad Dermatol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/S0190-9622(88)70279-0","article-title":"Fibrous papule: a tumor of fibrohistiocytic cells that contain factor XIIIa","volume":"19","author":"AJ Nemeth","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/archderm.1962.01590020049006","article-title":"Tuberous sclerosis. Special reference to the microscopic alterations in the cutaneous hamartomas","volume":"85","author":"WR Nickel","year":"1962","journal-title":"Arch Dermatol"},{"key":"ref9","first-page":"774","article-title":"Tuberous sclerosis: diagnostic criteria and new treatment approaches","volume":"59","author":"S Grieb","year":"2008","journal-title":"Hautarzt"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/0092-8674(93)90618-Z","article-title":"Identification and characterization of the tuberous sclerosis gene on chromosome 16","volume":"75","author":"ECTS Consortium","year":"1993","journal-title":"Cell"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1126\/science.277.5327.805","article-title":"Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34","volume":"277","author":"M van Slegtenhorst","year":"1997","journal-title":"Science"},{"key":"ref12","first-page":"4766","article-title":"Hamartin, the product of the tuberous sclerosis 1 (TSC1) gene, interacts with tuberin and appears to be localized to cytoplasmic vesicles","volume":"58","author":"TL Plank","year":"1998","journal-title":"Cancer Res"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/ncb839","article-title":"TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling","volume":"4","author":"K Inoki","year":"2002","journal-title":"Nat Cell Biol"},{"key":"ref14","first-page":"5645","article-title":"Activated mammalian target of rapamycin pathway in the pathogenesis of tuberous sclerosis complex renal tumors","volume":"62","author":"HL Kenerson","year":"2002","journal-title":"Cancer Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/gcc.10256","article-title":"Multiple roles of the tuberous sclerosis complex genes","volume":"38","author":"RS Yeung","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/ng1494","article-title":"Dysregulation of the TSC-mTOR pathway in human disease","volume":"37","author":"K Inoki","year":"2005","journal-title":"Nat Genet"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/S0140-6736(03)13044-9","article-title":"Mutation in TSC2 and activation of mammalian target of rapamycin signalling pathway in renal angiomyolipoma","volume":"361","author":"N El-Hashemite","year":"2003","journal-title":"Lancet"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/modpathol.3800610","article-title":"Frequent [corrected] hyperphosphorylation of ribosomal protein S6 [corrected] in lymphangioleiomyomatosis-associated angiomyolipomas","volume":"19","author":"VA Robb","year":"2006","journal-title":"Mod Pathol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.humpath.2007.01.028","article-title":"Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasms","volume":"38","author":"H Kenerson","year":"2007","journal-title":"Hum Pathol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/path.2289","article-title":"Constant allelic alteration on chromosome 16p (TSC2 gene) in perivascular epithelioid cell tumour (PEComa): genetic evidence for the relationship of PEComa with angiomyolipoma","volume":"214","author":"CC Pan","year":"2008","journal-title":"J Pathol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1136\/jmg.33.11.962","article-title":"Loss of heterozygosity in tuberous sclerosis hamartomas","volume":"33","author":"T Sepp","year":"1996","journal-title":"J Med Genet"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1073\/pnas.0712397105","article-title":"Mesenchymal-epithelial interactions involving epiregulin in tuberous sclerosis complex hamartomas","volume":"105","author":"S Li","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/ncomms1236","article-title":"Human TSC2-null fibroblast-like cells induce hair follicle neogenesis and hamartoma morphogenesis","volume":"2","author":"S Li","year":"2011","journal-title":"Nat Commun"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/archdermatol.2010.125","article-title":"Topical rapamycin: a novel approach to facial angiofibromas in tuberous sclerosis","volume":"146","author":"AK Haemel","year":"2010","journal-title":"Arch Dermatol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/j.1365-2133.2011.10476.x","article-title":"Treatment of facial angiofibromas with topical application of oral rapamycin solution (1mgmL(-1)) in two patients with tuberous sclerosis","volume":"165","author":"MM Mutizwa","year":"2011","journal-title":"Br J Dermatol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1365-2133.2011.10471.x","article-title":"A topical combination of rapamycin and tacrolimus for the treatment of angiofibroma due to tuberous sclerosis complex (TSC): a pilot study of nine Japanese patients with TSC of different disease severity","volume":"165","author":"M Wataya-Kaneda","year":"2011","journal-title":"Br J Dermatol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3109\/09546634.2010.489598","article-title":"Successful treatment of angiofibromata of tuberous sclerosis complex with rapamycin","volume":"23","author":"E Kaufman McNamara","year":"2012","journal-title":"J Dermatolog Treat"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/j.1468-3083.2011.04212.x","article-title":"Sustained clinical effectiveness and favorable safety profile of topical sirolimus for tuberous sclerosis - associated facial angiofibroma","volume":"26","author":"R Salido","year":"2012","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"Calonje E (2010) Soft-Tissue Tumours and Tumour-like Conditions. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rook&apos;s Textbook of Dermatology. 8th edition. Oxford, UK: Wiley-Blackwell. doi:10.1002\/9781444317633.ch56.","DOI":"10.1002\/9781444317633.ch56"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2133.1971.tb07194.x","article-title":"Fibrous papule of the nose","volume":"85","author":"T Saylan","year":"1971","journal-title":"Br J Dermatol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1067\/mjd.2001.116223","article-title":"Treatment of angiofibromas with a scanning carbon dioxide laser: a clinicopathologic study with long-term follow-up","volume":"45","author":"RC Bittencourt","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1034\/j.1600-0560.2003.2o066.x","article-title":"Loss of expression of tuberin and hamartin in tuberous sclerosis complex-associated but not in sporadic angiofibromas","volume":"30","author":"I Fackler","year":"2003","journal-title":"J Cutan Pathol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1086\/316951","article-title":"Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs","volume":"68","author":"SL Dabora","year":"2001","journal-title":"Am J Hum Genet"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nm0202-128","article-title":"Rapamycin inhibits primary and metastatic tumor growth by antiangiogenesis: involvement of vascular endothelial growth factor","volume":"8","author":"M Guba","year":"2002","journal-title":"Nat Med"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"5549","DOI":"10.1158\/0008-5472.CAN-05-2825","article-title":"Antiangiogenic potential of the mammalian target of rapamycin inhibitor temsirolimus","volume":"66","author":"D Del Bufalo","year":"2006","journal-title":"Cancer Res"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Tyburczy ME, Wang JA, Li S, Thangapazham R, Chekaluk Y, <etal>et al<\/etal>.. (2013) Sun exposure causes somatic second-hit mutations and angiofibroma development in tuberous sclerosis complex. Hum Mol Genet. In press.","DOI":"10.1093\/hmg\/ddt597"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1600-0560.2006.00667.x","article-title":"Epithelioid fibrous papule - a new variant","volume":"34","author":"C Kucher","year":"2007","journal-title":"J Cutan Pathol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/00000372-200012000-00018","article-title":"Fibrous papule with clear fibrocytes","volume":"22","author":"C Rose","year":"2000","journal-title":"Am J Dermatopathol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"358","author":"JJ Bissler","year":"2008","journal-title":"N Engl J Med"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa1001671","article-title":"Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis","volume":"363","author":"DA Krueger","year":"2010","journal-title":"N Engl J Med"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"e23379","DOI":"10.1371\/journal.pone.0023379","article-title":"Multicenter phase 2 trial of sirolimus for tuberous sclerosis: kidney angiomyolipomas and other tumors regress and VEGF- D levels decrease","volume":"6","author":"SL Dabora","year":"2011","journal-title":"PLoS one"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"4071","DOI":"10.1158\/1078-0432.CCR-11-0445","article-title":"Sirolimus therapy for angiomyolipoma in tuberous sclerosis and sporadic lymphangioleiomyomatosis: a phase 2 trial","volume":"17","author":"DM Davies","year":"2011","journal-title":"Clin Cancer Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1053\/j.ajkd.2011.10.013","article-title":"Tuberous sclerosis complex\u2013associated angiomyolipomas: focus on mTOR Inhibition","volume":"59","author":"K Budde","year":"2012","journal-title":"Am J of Kidney Dis"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0140-6736(12)61134-9","article-title":"Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial","volume":"381","author":"DN Franz","year":"2013","journal-title":"Lancet"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1365-2133.2008.08677.x","article-title":"The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis","volume":"159","author":"GF Hofbauer","year":"2008","journal-title":"Br J Dermatol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0089467","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T19:07:10Z","timestamp":1565204830000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0089467"}},"subtitle":[],"editor":[{"given":"H. Peter","family":"Soyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,2,18]]},"references-count":45,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,2,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0089467","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,18]]}}}